Evidence map›Paper›PMID 31974413›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Exome sequencing in newborns with congenital deafness as a model for genomic newborn screening: the Baby Beyond Hearing project.

Lilian Downie, Jane Halliday, Sharon Lewis, Sebastian Lunke, Elly Lynch, Melissa Martyn, Clara Gaff, Anna Jarmolowicz, David J Amor

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Perception of genomic newborn screening among peripartum mothers.European journal of human genetics : EJHG · 2024
    Article
  12. Article
  13. Genomic newborn screening for rare diseases.Nature reviews. Genetics · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. [Genetics of pediatric hearing loss].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023
    Review
  19. [The critical thoughts on diagnosis and treatment of childhood hearing loss].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lilian DownieVictorian Clinical Genetics Services, Melbourne, Australia.
Jane HallidayMurdoch Children's Research Institute, Melbourne, Australia.
Sharon LewisMurdoch Children's Research Institute, Melbourne, Australia.
Sebastian LunkeVictorian Clinical Genetics Services, Melbourne, Australia.
Elly LynchVictorian Clinical Genetics Services, Melbourne, Australia.
Melissa MartynMurdoch Children's Research Institute, Melbourne, Australia.
Clara GaffDepartment of Paediatrics, University of Melbourne, Melbourne, Australia.
Anna JarmolowiczVictorian Clinical Genetics Services, Melbourne, Australia.
David J AmorVictorian Clinical Genetics Services, Melbourne, Australia. david.amor@mcri.edu.au.ORCID http://orcid.org/0000-0001-7191-8511
The University of Melbourne · AURoyal Children's Hospital · AUVictorian Clinical Genetics Services · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGenomic newborn screening raises practical and ethical issues. Evidence is required to build a framework to introduce this technology safely and effectively. We investigated the choices made by a diverse group of parents with newborns when offered tiered genomic information from exome sequencing.

methodsThis population-derived cohort comprised infants with congenital deafness. Parents were offered exome sequencing and choice regarding the scope of analysis. Options were choice A, diagnostic analysis only; choice B, diagnostic analysis plus childhood-onset diseases with medical actionability; or choice C, diagnostic analysis plus childhood-onset diseases with or without medical actionability.

resultsOf the 106 participants, 72 (68%) consented to receive additional findings with 29 (27.4%) selecting choice B and 43 (40.6%) opting for choice C. Family size, ethnicity, and age of infant at time of recruitment were the significant predictors of choice. Parents who opted to have additional findings analysis demonstrated less anxiety and decisional conflict.

conclusionsThese data provide evidence from a culturally diverse population that choice around additional findings is important and the age of the infant when this choice is offered impacts on their decision. We found no evidence that offering different levels of genomic information to parents of newborns has a negative psychological impact.

Indexed as

DeafnessNeonatal ScreeningChildExomeGenetic TestingGenomicsHearingHumansInfantInfant, Newbornexome sequencinggenomic sequencingnewbornnewborn screeningnewborn sequencing

Identifiers

PMID31974413
OpenAlexW3001360924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.